
🔔 Good morning, and welcome to Telda Lens — your daily pulse on Egypt’s markets.
Today: We have the latest on Macro Capital's financial performance in 2025 + updates from Qatar National Bank regarding its dividend distribution plan and news about its new bond program
Market overview
EGX Pulse

🔔 EGX30 ended -2.98% by market close at 50,667 points, the EGX70 fell 2.96% to 12,726 points, and the EGX100 also dropped 2.92% to reach 17,804 points
💸 The number of transactions reached 146,106 spread across 1,401,821,832 stocks leading to a turnover of EGP 5.6 billion.
🏷️ Regional investors were the sole net sellers.
📈 Top gainers across the broader market Minapharm Pharmaceuticals (+7.0%), Misr Oils & Soap (+5.4%), and Cairo Educational Services (+3.3%).
📉 Top losers: Cairo Poultry (-10.3%), Arab Valves Company (-8.4%), Egyptian Transport “EGYTRANS” (-6.2%.)
⬆️ The only gainer in the EGX30 on Thursday was Rameda (+2.4%).
⬇️ Top EGX30 losers included: Ibnsina Pharma (-5.4%), Raya Holding (-5.3%), and TMG Holding (-5.0%).
Other Important Stats:
🧈 24K Gold reached EGP 7,616 per gram, up 0.20% day-on-day and up 6.22% month-on-month.
💲 The USD reached EGP 47.54 at the National Bank of Egypt.
Corporate Corner
Macro Capital swings to profitability in 2025

Macro Group Pharmaceutical Industries – Macro Capital (MCRO) reported a return to profitability in 2025, according to its disclosure to the EGX on Thursday.
The company posted net profit of EGP 115.82 million, compared with a net loss of EGP 38.04 million in 2024, after minority interest.
Sales rose sharply to EGP 894.54 million last year from EGP 519.97 million a year earlier, reflecting strong growth in business activity.
Stock performance:
The company has seen strong momentum in 2026, with its share value rising 24% since the beginning of the year. This brings its gains over the past 12 months to 214%.
Refresher:
Macro Group is a leading Egyptian cosmeceutical company, manufacturing and marketing a diverse range of skin, hair, and personal care products. They hold a strong market leadership in Egypt, distributing through physician prescriptions, pharmacies, and increasingly online.
The company also exports its products to over 10 countries in the Middle East and Africa.
Corporate Corner
QNB Egypt announces FY2025 dividend and greenlights EGP 50 billion bond program

Shareholders of QNB Egypt (QNBE) are set to receive a cash dividend of EGP 2 per share for the 2025 financial year, according to an EGX filing. The distribution totals roughly EGP 4.3 billion and implies a yield of 4.8% based on the stock’s latest close of EGP 41.66.
Payout ratio and earnings growth
The dividend represents a payout ratio of approximately 33% of FY2025 net income, which rose 13.6% year-on-year to reach EGP 30.1 billion.
Recent stock performance
The company has had a rough start to the year, with its share value down 10% since the start of 2026. However, over the past year the stock has gained 32%
In other news: its EGM approved a major bond program
Separately, the bank’s extraordinary general assembly approved a bond issuance program worth up to EGP 50 billion. The bonds will be issued in multiple tranches between 2026 and 2029 as funding needs arise, with the board determining terms and pricing for each issuance subject to regulatory approvals.

